Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | L158Q |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | VHL L158Q lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). L158Q retains the ability to bind and ubiquitinate Hif1a in an in vitro assay (PMID: 26503325), however, is predicted to lead to a loss of Vhl protein function as demonstrated by decreased Elongin C binding and increased ubiquitination by Ube2s leading to reduced Vhl protein stability and impaired regulation of Hif target genes and cell proliferation in culture (PMID: 26503325). |
Associated Drug Resistance | |
Category Variants Paths |
VHL mutant VHL inact mut VHL L158Q |
Transcript | NM_000551.4 |
gDNA | chr3:g.10149796T>A |
cDNA | c.473T>A |
Protein | p.L158Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000551.3 | chr3:g.10149796T>A | c.473T>A | p.L158Q | RefSeq | GRCh38/hg38 |
NM_000551.4 | chr3:g.10149796T>A | c.473T>A | p.L158Q | RefSeq | GRCh38/hg38 |
NM_000551 | chr3:g.10149796T>A | c.473T>A | p.L158Q | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|